Canvas Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,969
Closed -$943K 132
2023
Q3
$943K Sell
12,969
-2,943
-18% -$246K 0.39% 47
2023
Q2
$1.41M Sell
15,912
-1,235
-7% -$106K 0.52% 37
2023
Q1
$1.57M Buy
17,147
+12,585
+276% +$1.03M 0.66% 28
2022
Q4
$359K Buy
+4,562
New +$370K 0.15% 100
2022
Q2
Sell
-2,477
Closed -$255K 140
2022
Q1
$255K Sell
2,477
-111
-4% -$11.7K 0.09% 121
2021
Q4
$268K Buy
2,588
+504
+24% +$58.4K 0.1% 116
2021
Q3
$261K Sell
2,084
-144
-6% -$18.6K 0.11% 103
2021
Q2
$277K Buy
2,228
+565
+34% +$70.9K 0.12% 100
2021
Q1
$203K Buy
+1,663
New +$195K 0.12% 111

Other funds holding MDT

Canvas Wealth Advisors's MDT Position: Q4 2023 in Review

Canvas Wealth Advisors sold out of Medtronic (MDT) in Q4 2023, closing a stake of 12,969 shares — an estimated $943K sold.

Canvas Wealth Advisors first reported a position in MDT in Q1 2021 and held it in 9 quarters. The position peaked at $1.57M in Q1 2023. 2,074 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

  • Canvas Wealth Advisors reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
  • Canvas Wealth Advisors sold 12,969 Medtronic shares in Q4 2023, an estimated $943K.
  • Canvas Wealth Advisors first reported a position in Medtronic in Q1 2021 and held it in 9 quarters.
  • Canvas Wealth Advisors's Medtronic position peaked at $1.57M in Q1 2023.
  • 2,074 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on Canvas Wealth Advisors's 13F filing for Q4 2023, filed 17 Jan 2024.